Department of Cardiac Sciences, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
Cardiovascular Genetics Center, Montreal Heart Institute, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
JACC Clin Electrophysiol. 2023 Dec;9(12):2494-2503. doi: 10.1016/j.jacep.2023.08.017. Epub 2023 Oct 4.
There is growing evidence that mitral valve prolapse (MVP) is associated with otherwise unexplained cardiac arrest (UCA). However, reports are hindered by the absence of a systematic ascertainment of alternative diagnoses.
This study reports the prevalence and characteristics of MVP in a large cohort of patients with UCA.
Patients were enrolled following an UCA, defined as cardiac arrest with no coronary artery disease, preserved left ventricular ejection fraction, and no apparent explanation on electrocardiogram. A comprehensive evaluation was performed, and patients were diagnosed with idiopathic ventricular fibrillation (IVF) if no cause was found. Echocardiography reports were reviewed for MVP. Patients with MVP were divided into 2 groups: those with IVF (AMVP) and those with an alternative diagnosis (nonarrhythmic MVP). Patient characteristics were then compared. The long-term outcomes of AMVP were reported.
Among 571 with an initially UCA, 34 patients had MVP (6%). The prevalence of definite MVP was significantly higher in patients with IVF than those with an alternative diagnosis (24 of 366 [6.6%] vs 5 of 205 [2.4%]; P = 0.03). Bileaflet prolapse was significantly associated with AMVP (18 of 23 [78%] vs 1 of 8 [12.5%]; P = 0.001; OR: 25.2). The proportion of patients with AMVP who received appropriate implantable cardioverter-defibrillator therapies over a median follow-up of 42 months was 21.1% (4 of 19).
MVP is associated with otherwise UCA (IVF), with a prevalence of 6.6%. Bileaflet prolapse appears to be a feature of AMVP, although future studies need to ascertain its independent association. A significant proportion of patients with AMVP received appropriate implantable cardioverter-defibrillator therapies during follow-up.
越来越多的证据表明,二尖瓣脱垂(MVP)与不明原因的心脏骤停(UCA)有关。然而,由于缺乏对其他诊断的系统确定,相关报告受到阻碍。
本研究报告了在一大群 UCA 患者中 MVP 的患病率和特征。
在 UCA 后招募患者,UCA 定义为无冠状动脉疾病、左心室射血分数正常且心电图无明显异常的心脏骤停。对患者进行全面评估,如果未发现病因,则诊断为特发性室颤(IVF)。对超声心动图报告进行 MVP 审查。将 MVP 患者分为 2 组:IVF 伴 MVP(AMVP)和其他诊断伴 MVP(非心律失常性 MVP)。然后比较患者特征。报告 AMVP 的长期预后。
在最初的 UCA 患者中,有 571 名患者有 MVP(6%)。IVF 患者中 MVP 的明确患病率明显高于其他诊断患者(24/366[6.6%] vs. 5/205[2.4%];P=0.03)。双叶脱垂与 AMVP 显著相关(18/23[78%] vs. 1/8[12.5%];P=0.001;OR:25.2)。在中位随访 42 个月期间,接受适当植入式心律转复除颤器治疗的 AMVP 患者比例为 21.1%(4/19)。
MVP 与 UCA(IVF)有关,患病率为 6.6%。双叶脱垂似乎是 AMVP 的特征,但未来的研究需要确定其独立相关性。在随访期间,相当一部分 AMVP 患者接受了适当的植入式心律转复除颤器治疗。